Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 473.834 million compared to CNY 627.170 million a year ago. Operating income was CNY 598.859 million compared to CNY 37.267 million a year ago. Net income was CNY 586.291 million compared to CNY 28.110 million a year ago. Basic earnings per share from continuing operations was CNY 1.89 compared to CNY 0.09 a year ago.